colorectal cancer

From FOXFIRE to the Future: What Recently Published Studies Mean for IO

09/28/2017

In this interview with Interventional Oncology 360, Daniel Brown, MD, FSIR, chief of interventional oncology at Vanderbilt University, discusses recent changes to his practice. He also comments on the results of the FOXFIRE Global study and...

In this interview with...

09/28/2017

IO Learning

News

Colorectal Cancer Risk Linked to Inflammatory Diets

09/01/2017

Previous studies have linked colorectal cancer risk with diets that cause systemic and local intestinal inflammation. In a new study, researchers investigated whether diets that increased intestinal inflammation were associated with risk for...

Previous studies have linked...

09/01/2017

Gastroenterology

News

Patient Education, Support May Increase CRC Screening

07/24/2017

In a recent study, researchers evaluated the efficacy of certain patient-oriented tools and strategies in increasing the rate of colorectal cancer screenings. To see results of the study, including which patient populations benefited the...

In a recent study, researchers...

07/24/2017

Gastroenterology

News

Colorectal Cancer Risk Lessened With Mediterranean Diet Adherence

06/30/2017

In a recent study, researchers investigated the relationship between individual and combined components of the Mediterranean diet and risk of colorectal polyps.

In a recent study, researchers...

06/30/2017

Gastroenterology

Research in Review

Significant Cost Savings From Enhanced Recovery Pathway for Colorectal Surgery

11/15/2016

JCP Editors

A new study has shown that an Enhanced Recovery After Surgery (ERAS) pathway for colorectal surgery can help to reduce complications from health services utilization and significantly reduce total...

A new...

11/15/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz: Week of Sept 25‚ÄîOct 1

09/29/2016

JCP Editors

Bevacizumab, added to standard adjuvant therapy with capecitabine, offered no benefit to patients with which of the following cancer types? colorectal cancer small cell lung cancer non-small cell lung...

...

09/29/2016

Journal of Clinical Pathways

Research in Review

Protein Predicts Prognosis in Gastric Cancer

08/02/2016

JCP Editors

The protein calpain-9 may be an independent factor for poor prognosis that, when combined with TNM stage, may provide a better predictive model for outcomes in patients with gastric cancer, according to a study...

The...

08/02/2016

Journal of Clinical Pathways

Research in Review

Genetic Variant of Rectal Cancer Predicts Prognosis, Treatment Response

07/25/2016

JCP Editors

DNA mismatch repair (dMMR) deficiency rectal cancer is associated with excellent prognosis and pathologic response with current therapeutic options and surgical procedures, according to research published in the...

DNA...

07/25/2016

Journal of Clinical Pathways

Research in Review

Adjuvant Chemotherapy Improves Colon Cancer Outcomes

07/22/2016

JCP Editors

Adjuvant chemotherapy may improve survival in patients with stage II colon cancer regardless of treatment regimen, patient age, or high-risk pathologic features, according to a study published in the journal Cancer....

...

07/22/2016

Journal of Clinical Pathways

Department

Peri-operative Chemo and Radiotherapy Equally Effective for Gastric Cancer

07/06/2016

JCP Editors

Post-operative chemotherapy may be just as effective as chemoradiotherapy in patients with gastric cancer who have already undergone pre-operative chemotherapy, according to phase III data presented at the European...

...

07/06/2016

Journal of Clinical Pathways